Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy.

CONCLUSION: This preclinical data support the use of Taraxacum as a potential adjuvant application in pediatric oncology.
PMID: 30219442 [PubMed - in process]

Source: Complementary Therapies in Medicine - September 18, 2018 Category: Complementary Medicine Authors: Menke K, Schwermer M, Felenda J, Beckmann C, Stintzing F, Schramm A, Zuzak TJ Tags: Complement Ther Med Source Type: research